Four insights:
1. The CE Mark allows Nexus and its disposable products to be commercialized across the European Union and CE Mark countries.
2. The Nexus device is driven by a digital algorithm that aims to increase power, efficiency and control.
3. It aims to improve resection rates and help surgeons perform more efficient bone removal procedures.
4. Misonix sees the new technology as a strategic growth opportunity to expand its European footprint.
More articles on devices:
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
The big trends, issues in spine shaping practices today
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
